MARKET

VANI

VANI

Vivani Medical
NASDAQ
1.400
-0.010
-0.71%
After Hours: 1.370 -0.03 -2.15% 18:15 12/05 EST
OPEN
1.430
PREV CLOSE
1.410
HIGH
1.470
LOW
1.393
VOLUME
93.52K
TURNOVER
--
52 WEEK HIGH
1.920
52 WEEK LOW
0.9054
MARKET CAP
102.13M
P/E (TTM)
-3.1696
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VANI last week (1124-1128)?
Weekly Report · 5d ago
Vivani Medical Inc. unveils presentation on subdermal semaglutide implant for chronic weight management
Reuters · 11/24 21:45
Weekly Report: what happened at VANI last week (1117-1121)?
Weekly Report · 11/24 09:05
Vivani Medical’s NPM-139: A Promising Semaglutide Implant with Strong Buy Rating
TipRanks · 11/18 11:25
Director’s Bold Move: Massive Stock Purchase in Vivani Medical!
TipRanks · 11/18 02:08
Director and 10% Owner Gregg Williams Reports Acquisition of Vivani Medical Inc. Common Shares
Reuters · 11/17 14:00
Weekly Report: what happened at VANI last week (1110-1114)?
Weekly Report · 11/17 09:05
Vivani Medical’s Innovative Semaglutide Implant and Market Positioning Drive Buy Recommendation
TipRanks · 11/14 19:35
More
About VANI
Vivani Medical, Inc. is a clinical-stage biopharmaceutical company, developing miniature, ultra-long-acting drug implants. Leveraging its NanoPortal platform, it develops biopharmaceutical implants designed to deliver drug molecules steadily over extended periods of time with the goal of guaranteeing adherence, and to improve patient tolerance to their medication. Its lead program, NPM-115, is a six-month, subdermal, GLP-1 (exenatide) implant under development for chronic weight management in overweight individuals. Its pipeline includes NPM-139 (semaglutide implant), which is also under development for chronic weight management. NPM-119 refers to its six-month, subdermal, GLP-1 (exenatide) implant under development for the treatment of type 2 diabetes. These NanoPortal implants are designed to provide patients with the opportunity to realize the benefit of their medication by avoiding the challenges associated with the daily or weekly administration of orals and injectables.

Webull offers Vivani Medical Inc stock information, including NASDAQ: VANI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VANI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VANI stock methods without spending real money on the virtual paper trading platform.